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Background: Dengue fever (DF) and malaria are the two major public health concerns in tropical countries such as
Thailand. Early differentiation between dengue and malaria could help clinicians to identify patients who should be
closely monitored for signs of dengue hemorrhagic fever or severe malaria. This study aims to build knowledge on
diagnostic markers that are used to discriminate between the infections, which frequently occur in malaria-endemic
areas, such as the ones in Thailand.
Methods: A retrospective study was conducted in Phop Phra Hospital, a hospital located in the Thailand-Burma
border area, a malaria-endemic area, between 2013 and 2015. In brief, data on 336 patients infected with malaria
were compared to data on 347 patients infected with DF.
Results: White blood cells, neutrophil, monocyte, eosinophil, neutrophil-lymphocyte ratio, and monocyte-lymphocyte
ratio were significantly lower in patients with DF compared to patients with malaria (P < 0.0001). In contrast, red blood
cells, hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, and mean corpuscular
hemoglobin concentration were significantly higher in patients with DF as compared to patients with malaria
(P < 0.0001). A decision tree model revealed that using neutrophils, lymphocyte, MCHC, and gender was
guided to discriminate between dengue and malaria infection.
Conclusion: This study concluded that several hematological parameters were different for diagnosing DF
and malaria. A decision tree model revealed that using neutrophils, lymphocyte, MCHC, and gender was
guided to discriminate patients with dengue and malaria infection. In addition, using these markers will thus
lead to early detection, diagnosis, and prompt treatment of these tropical diseases.
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Please see Additional file 1 for translations of the
abstract into the five official working languages of the
United Nations.Background
Dengue fever (DF) and malaria are the two most
common arthropod-borne diseases in tropical countries,
especially in Southeast Asian regions, where their
endemic areas greatly overlap [1, 2]. The clinical* Correspondence: manas.ko@wu.ac.th
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are difficult to distinguish between each other. Currently
in 2015, the World Health Organization (WHO) reports
that P. vivax malaria makes up 75% of all malaria cases,
and most cases of P. vivax malaria occurred in the
WHO South-East Asia Region (74%) [1]. In 2009, 23 229
cases of malaria and 19 deaths were reported in
Thailand, with P. vivax being responsible for half of the
total cases [2, 3].
Dengue fever is caused by the dengue virus (DENV) in
one of the four serotypes: DENV-1, DENV-2, DENV-3,
and DENV-4 [4]. According to estimates of the WHO,
about 50 million patients are infected with DF annually
worldwide and 2.5 billion people live in risk areas [5].le is distributed under the terms of the Creative Commons Attribution 4.0
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nine deaths reported in 2014 [6]. Dengue infection can
range from a nonspecific febrile illness, as in DF, to a more
severe illness with bleeding tendency, thrombocytopenia,
and plasma leakage (dengue hemorrhagic fever, DHF) [7].
At presentation, DF and other febrile illnesses share simi-
lar clinical characteristics, including headache, myalgia,
and rash. However, clinical characteristics of DHF, such as
bleeding and plasma leakage, are seen at a later stage of
the febrile phase after the third or fourth day of fever.
Patients are classified as having DHF, according to the
WHO guidelines, based on all of the following four signs:
fever, thrombocytopenia (platelet count < 100 000/μL),
bleeding (positive tourniquet test or spontaneous bleed-
ing), and plasma leakage (evidence of pleural effusion,
ascites or ≥ 20% hemoconcentration) [8].
In Thailand, DF and malaria coexist, and are both
prevalent. Early differentiation between dengue and mal-
aria could help clinicians to identify patients who should
be closely monitored for signs of DHF or severe malaria.
Differences in clinical and laboratory features between
DF and malaria have been reported, however, published
studies vary on information pertaining to the duration of
symptoms and demographic of patients.
Phop Phra Hospital is located in Tak Province, a terri-
tory located in the western part of Thailand, which
shares a long border with Kayin State, Myanmar. It is
part of the Thailand-Myanmar border area and is the
most common destination for people from Myanmar
who migrate to Thailand for agricultural work. During
malaria endemics, large numbers of patients with fever
and other febrile illnesses are admitted weekly to emer-
gency. There is risk of misdiagnosing malaria cases as
DF cases in a malaria-endemic area, as the two diseases
share similar clinical and laboratory characteristics. In
addition, it may be impossible to both examine for
dengue and malaria for all patients exhibiting similar
signs and symptoms.
The objective of this study was to identify clinical and
laboratory features that can differentiate between pa-
tients infected with dengue and those infected with
malaria, as well as to build knowledge about diagnostic
markers used to discriminate DF from malaria, which
both frequently occur in malaria-endemic areas.
Methods
A retrospective case-control study designed to differen-
tiate between dengue and malaria was performed
between January 2013 and December 2015 at the
Medical Technology Laboratory of Phop Phra Hospital,
Tak Province, Thailand.
In brief, the patients infected only with DF and those
infected only with malaria were exhaustively identified
based on the date of microbiological diagnosis. Thediagnosis of malaria relied on the identification of sporo-
zoa on thick/thin blood film stained with Giemsa and
the identification of parasites under a light microscope
by medical laboratorists. Thick and thin blood films
were prepared by collecting venous blood in an Ethyl-
enediaminetetraacetic acid (EDTA) tube and staining it
with diluted Giemsa (1:10). One thousand red blood
cells (RBCs) on the thin blood film and 200 white blood
cells (WBCs) on the thick smear were examined before
classifying a case as negative. EDTA blood were also
analysed to determine the complete blood counts
(CBCs) using a BC-5200 Hematology Analyzer (Mind-
ray, Nanshan, Shenzhen, China). The analyzer provided
data on RBC count, hemoglobin (Hb), hematocrit (Hct),
platelet count, WBC count, neutrophil, monocyte, lympho-
cyte and eosinophil counts, mean corpuscular volume
(MCV), mean corpuscular hemoglobin (MCH), and mean
corpuscular hemoglobin concentration (MCHC).
Dengue can be diagnosed in laboratories using differ-
ent methods. Nonstructural protein 1 (NS1) antigen de-
tection was performed from day 0 to day 5, and indirect
diagnosis based on the detection of specific anti-dengue
immunoglobulin M (IgM) or immunoglobulin G (IgG)
antibodies in patients’ sera after day 3 [9]. At least one
positive test was taken to mean a positive dengue infec-
tion. Data were retrieved anonymously from patients
and from computerized medical records, and included
socioepidemiologic characteristics, previous medical his-
tory, and biological results.
A normal distribution of continuous data were deter-
mined using the Kolmogorov-Smirnov test. Continuous
variables were categorized following laboratory or usual
cut-off values. For example, WBCs < 4 000/μL, neutro-
phils < 2 800/μL, lymphocytes < 800/μL, monocytes < 80/
μL, eosinophils < 40/μL, basophils < 16/μL, RBCs < 4 ×
106/μL, Hb < 11 g/dL, and platelets < 100 000/μL were
considered lower than cut-off values. Hematocrit > 40%,
MCV > 80 fL, MCH > 25 pg/cell, MCHC > 33 g/dL, and
red cell distribution width (RDW) >13% were considered
higher than cut-off values. Continuous variables were
compared using the Mann–Whitney U test. Categorical
variables were analysed using the Fisher’s exact test or
chi-square test. Statistical significance was set at P-value
less than 0.05. Univariate logistic regression model was
performed to confirm that associations between vari-
ables were independent of age, gender, and nationality.
Variables with P-values of less than 0.05 in univariate
logistic regression analyses were entered into a multi-
variate logistic regression model. Conditional multi-
variate backward stepwise logistic regression was then
performed to calculate the adjusted odds ratios (ORs)
and 95% confidence intervals (95%CIs). All significant
variables in the univariate and multivariate logistic
model were then used to determine a diagnostic value of
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hematological parameters was measured by calculating
their sensitivity, specificity, predictive values, and ORs
and 95%CIs.
A decision tree model (RapidMiner studio basic v7.1,
RapidMiner, Inc., USA) was built to analyse parameters
related to dengue and malaria infection. The goal of the
analysis was to identify the most important parameters
using the demographic data of the study population and
hematological parameters.
Results
Demographic data of the study population
The 683 patients who were investigated in this study had
a median age of 19 years (interquartile range, IQR: 10–31
in the dengue group, 11–34 in the malaria group). No sig-
nificant differences relating to age were observed between
the two groups (P = 0.299). There were more women
(51.6%) in the dengue group and more men (61.3%) in the
malaria group. A significant difference relating to gender
between the two groups was observed (P = 0.001, OR
95%CI = 0.59 [0.44–0.80]). The large majority of people in
both groups were Thai (dengue group = 74.1%; malaria
group = 52.1%). A significant difference relating to nation-
ality between the two groups was observed (P < 0.0001,
OR 95%CI = 2.6 [1.91–3.62]) (see Table 1).
Microbiological results
Out of the study cohort, 336 patients were infected with
malaria. Of those, 72.9% were infected with P. vivax and
21.1% were infected with P. falciparum. Meanwhile, 347
patients were infected with dengue. Of these, 20.7% were
positive with NS1 antigen but IgM or IgG test was not
tested, 17.6% were positive with dengue IgG antibody
but NS1 antigen was not tested, and 12.4% were positive
just with IgM antibody. Co-infection of dengue and
malaria was not found. The microbiological results are
shown in Table 2.
Hematological values of the study population
The following parameters were significantly lower in




Age, median (IQR) 19 (10–31)
Male/female, n (%) 168 (48.4)/179 (51.6)
Thai/non-Thai, n (%) 257 (74.1)/90 (25.9)
*Comparison of the two groups was done using the Mann-Whitney U Test
**Comparison of the two groups was done using the chi-square test(P-value less than 0.0001): WBCs, neutrophil, mono-
cyte, eosinophil, NL ratio, and monocyte-lymphocyte
ratio (ML ratio). The following parameters were sig-
nificantly higher patients with DF as compared to pa-
tients with malaria (P < 0.0001): RBCs, Hb, Hct, MCV,
MCH, and MCHC (P < 0.009). The following parame-
ters were not significantly difference in patients with
DF compared to patients with malaria (P > 0.05):
lymphocyte, basophil, RDW, and platelet count (see
Table 3).
Diagnostic values of hematological parameters
Most of the hematological parameters had average
sensitivity and specificity to differentiating between
dengue and malaria. However, a MCH higher than
25 pg/cell had the highest sensitivity (78%) and an
eosinophil count less than 40 cells/μL had the highest
specificity (94%) to differentiate between patients with
DF and those with malaria. Hematological parameters
that had both good sensitivity and specificity were:
neutrophil count less than 2 800 cells/μL (sensitivity
66%, specificity 80%) and a NL ratio of less than 2.8
(sensitivity 72%, specificity 65%). Hematological pa-
rameters that had good ORs were WBC count less
than 4 000 cells/μL (OR = 7.52, 95%CI = 5.12–11.03),
neutrophil count less than 2 800 cells/μL (OR = 7.65,
95%CI = 5.41–10.82), and eosinophil count less than 40
cells/μL (OR = 7.63, 95%CI = 4.65–12.51) (see Table 4).
Regression analysis of parameters and dengue/malaria
infection
After adjusting for age, gender, and nationality in the
univariate regression model, the association between
hematological parameters (WBCs, neutrophil, monocyte,
eosinophil, NL ratio, ML ratio, RBCs, Hb, Hct, MCH)
and dengue infection were not confound (P < 0.05) (see
Table 5). After adjusting for age, gender, and nationality
of patients in the multivariate regression model, the
association between hematological parameters (WBCs,
neutrophil, monocyte, eosinophil, MCV, MCH, and
MCHC) and dengue infection were not confound (P < 0.05)





206 (61.3)/130 (38.7) 0.001**
(0.59, 0.44–0.80)
175 (52.1)/161 (47.9) <0.0001**
(2.6, 1.91–3.62)
Table 2 Laboratory diagnoses of dengue and malaria
Frequency Percentage (%)
Plasmodium sp.
P. vivax 245 72.9




+, NA, NA 72 20.7
NA, −, + 61 17.6
NA, +, − 43 12.4
+, −, − 36 10.4
-, +, + 35 10.1
NA, +, + 31 8.9
+, +, + 28 8.1
-, −, + 21 6.1
+, +, − 13 3.7
+, −, + 7 2
Total 347 100
NA Not applicable
Kotepui et al. Infectious Diseases of Poverty  (2017) 6:27 Page 4 of 9The decision tree model
The decision tree model generated from the dataset is
shown in Fig. 1. All individuals were divided into six
subgroups (six nodes) from root node (neutrophils) to
nodes (hemoglobin, lymphocyte, MCHC, and gender)






WBCs (×103/μL) 3.79 (2.64–5.51) 5.95 (4.81–7.51) <0.0001
Neutrophil (×103/μL) 2.19 (1.41–3.20) 4.12 (2.99–5.35) <0.0001
Lymphocyte (×103/μL) 1.05 (0.69–1.63) 1.05 (0.67–1.64) 0.607
Monocyte (×103/μL) 0.20 (0.11–0.33) 0.29 (0.14–0.54) <0.0001
Eosinophil (×103/μL) 0.05 (0.03–0.09) 0.11 (0.06–0.19) <0.0001
Basophil (×103/μL) 0.06 (0.03–0.12) 0.06 (0.04–0.09) 0.258
NL ratio 1.184 (1.15–1.84) 3.94 (2.17–7.23) <0.0001
ML ratio 0.17 (0.09–0.27) 0.27 (0.13–0.50) <0.0001
RBC (×106/μL) 5.02 (4.63–5.53) 4.66 (4.22–5.07) <0.0001
Hb (g/dL) 13.6 (12.4–15.0) 12.3 (10.8–13.4) <0.0001
HcT (%) 40 (36–44) 36 (32–40) <0.0001
MCV (fL) 81.4 (75–85.5) 78.4 (74.0–83.4) <0.0001
MCH (pg/cell) 27.8 (25.3–29.3) 26.5 (24.8–28.3) <0.0001
MCHC (g/dL) 34 (33.4–34.7) 33.9 (33–34.5) 0.009
RDW (%) 12.3 (11.9–13.0) 12.4 (11.8–13.1) 0.866
Platelet (×103/μL) 76 (45–101) 80.5 (52.3–119) 0.053
*Comparison of the two groups was done using the Mann-Whitney U Testleaf (dengue or malaria). The possibility to discriminate
dengue infection from malaria infection was varied
from 5% to 100%. For example, using neutrophils < 2 800/
μL, Hb < 11 g/dL, lymphocyte < 800/μL, and MCHC ≤
33 g/dL could help to increase specificity for discrim-
inating patients with DF. In addition, using neutro-
phils < 2 800/μL, Hb < 11 g/dL, lymphocyte < 800/μL,
and MCHC ≥ 33 g/dL, and female patients could help
to increase specificity for discriminating patients with
patients with malaria infection.
Discussion
The present study confirmed that sociodemographic
characteristics differ between patients with DF and those
with malaria.
Firstly, patients with DF tended to be younger than
patients with malaria, however, no significant difference
between the two infections and age were observed
(mean age DF = 22.5, malaria = 24.1 years old). This was
in concordance to another study, which indicated that
patients with DF tended to be younger (a quarter of the
study participants being below 15 years of age) [10]. It
has been reported that the incidence of malaria in
endemic areas decreases as people grow older, which
suggests that older age contributes to immunity against
malaria [11]. One possible explanation is age-related
differences in immune function leading to differences in
the balance between protective and harmful host im-
mune responses to P. falciparum [12]. Previous studies
have also suggested that the risk of developing severe
dengue is greater in DENV-infected children (<15 years)
than in adults [13, 14].
Secondly, significantly more male patients were in-
fected with malaria than with dengue in this study,
which a previous study also correlated [10]. This may
due to adult males reporting at least one journey into
the forest or working in the forest, which may have
made them more susceptible to getting bitten by a
malaria-borne mosquito.
Third, although over a third of the patients in this
study were from Burma, significantly more Thai patients
had DF than malaria. This could be explained by the fact
that dengue is transmitted in urban areas and not in the
forest. Most of the patients with malaria were infected
with P. vivax (73%), which was similar to a report from
the WHO [1]. Nowadays, drug-resistant P. vivax malaria
cases are increasing. It is usually assumed that P. falcip-
arum is the most likely Plasmodium species to cause
severe malaria, however, there is growing evidence that
P. vivax can also lead to severe complications [15].
In the present study, hematological presentation was
more severe and abnormalities were less frequent in
patients with DF than in those with malaria. This might
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Table 5 Univariate analysis of dengue/malaria infection and
hematological parameters adjusted by age, gender, and nationality
Parameters Dengue/malaria infection P-value Exp (B)
WBCs (×103/μL) 0.302 <0.0001 1.35
Neutrophil (×103/μL) 0.598 <0.0001 1.82
Monocyte (×103/μL) 1.54 <0.0001 4.67
Eosinophil (×103/μL) 6.65 <0.0001 772.95
NL ratio 0.209 <0.0001 1.23
ML ratio 2.116 <0.0001 8.29
RBCs (×106/μL) −0.943 <0.0001 0.389
Hb (g/dL) −0.458 <0.0001 0.632
HcT (%) −0.156 <0.0001 0.855
MCV (fL) −0.01 0.239 0.99
MCH (pg/cell) −0.099 <0.0001 0.906
MCHC (g/dL) −0.028 0.556 0.973
Kotepui et al. Infectious Diseases of Poverty  (2017) 6:27 Page 6 of 9presented early after the onset of symptoms. Red blood
cells, Hb, Hct, MCV, MCH, and MCHC were signifi-
cantly lower in patients with malaria. This may due to
the parasite’s primary target being RBCs, resulting in an
accelerated removal of both parasitized and non-
parasitized RBCs by the destruction of RBCs and bone
marrow dysfunction [16, 17]. One report indicated that
a high level of malaria parasitemia was associated with
high RBC destruction [18]. Anemia (Hb level < 11 g/dL)
was frequently found in malaria positive patients, espe-
cially patients infected with the P. falciparum strain [3].
Hemoconcentration and raised Hct are common in
patients with DHF [19]. A high Hct value is the initial
abnormality occurring in DHF due to plasma leakage.
Increase in Hct concentration by more than 20% of the
baseline Hct is an important diagnostic criterion [20].Table 6 Multivariate analysis of dengue/malaria infection and
hematological parameters adjusted by age, gender, and nationality
Parameters Dengue/malaria infection P-value Exp (B)
WBCs (×103/μL) −0.523 0.001 0.592
Neutrophil (×103/μL) 1.086 <0.0001 2.96
Monocyte (×103/μL) 1.98 0.037 7.28
Eosinophil (×103/μL) 4.86 <0.0001 130.3
NL ratio −0.004 0.910 0.995
ML ratio −0.002 0.997 0.997
RBCs (×106/μL) −0.031 0.659 0.968
Hb (g/dL) −0.054 0.815 0.947
HcT (%) −0.160 0.054 0.851
MCV (fL) 0.231 0.001 1.26
MCH (pg/cell) −0.638 0.001 0.528
MCHC (g/dL) 0.199 0.007 1.22
Constant −3.119 0.249 0.044This study found that the median Hct in patients with
dengue was 40%, which was in the normal range. How-
ever, diagnosis data of whether the patient had DHF
could not be obtained in this study, such as a positive
tourniquet test or spontaneous bleeding, and plasma
leakage [8]. This study found that a higher level of MCV,
MCH, and MCHC. However, association of these param-
eters and pathogenesis of malaria infection remain in-
conclusive. However, a previous study showed that those
parameters were higher in patients infected with malaria
as compared to the non-malaria infected group [3].
White blood cells, neutrophil, monocyte, eosinophil,
NL ratio, and ML ratio were significantly lower in pa-
tients with DF than in those with malaria. Leukopenia is
common in DF patients and a useful diagnostic marker
[7]. The total decrease in leukocyte count when a patient
has dengue is mainly due to a decrease in granulocytes
such as neutrophils [21]. Neutropenia in dengue infec-
tions has also been reported, but less frequently [22, 23].
However, it was more frequently observed in this study
(neutrophils were lower in 66% of patients with dengue).
A previous study indicated that severe neutropenia was
not associated with an increased risk of secondary
bacterial infections [24], but may be due to leukocytes
having been infected with DENV. Infected cells (den-
dritic cells and Langerhans cells) then migrate from the
site of infection to the lymph nodes, where monocytes
and macrophages are recruited, thus becoming targets of
infection [25]. The suppression of WBC production in
bone marrow by dengue virus may be a possible mech-
anism for lower leukocytes [26]. Presence of atypical
lymphocytes with activated lymphocytes is reported
consistently along with CBC parameters [21], but was
not applicable in this study. Both the NL ratio and ML
ratio in this study were significant lower in patients with
dengue than those with malaria due to a prominent
increase in the percentage and total number of lympho-
cytes, and an increase in the percentage and number of
atypical lymphocytes [22]. It has been reported that for
lower eosinophil counts in patients with dengue, eosino-
phil concentrations fell and during convalescence, the
eosinophil concentrations rose to a normal range in
response to inflammation during the acute phase of the
infection [27].
Previous studies have aimed to establish criteria to
differentiate between malaria attacks and DF. A study
performed in southern India to compare malaria to other
infectious causes of fever found that normal leukocyte
counts, moderate to severe thrombocytopenia, renal fail-
ure, splenomegaly, and hyperbilirubinemia with elevated
serum transaminases were associated with malaria.
However, rash, overt bleeding tendency, normal to low
leukocyte counts, moderate to severe thrombocytopenia,
and significantly elevated hepatic transaminases were
Fig. 1 Decision tree used to differentiate between patients with malaria and patients with dengue
Kotepui et al. Infectious Diseases of Poverty  (2017) 6:27 Page 7 of 9associated with DF [28]. A previous study also found that
patients with DF had a high packed cell volume (PCV),
whereas patients with malaria had a low PCV. In addition,
patients with malaria had the lowest platelet count
compared to patients with DF [29].
A low platelet count is a classic feature of both infections.
This study confirmed that both patients with DF and mal-
aria had low platelet counts, however, no significant differ-
ences between the two groups were observed. In many
tropical regions, fever with thrombocytopenia is assumed
to be malaria [3], and fever with thrombocytopenia and a
negative blood smear is thought to be DF [10]. In the
present study, thrombocytopenia (<100 000/μL) was less
common in patients with DF than in those with malaria
(DF = 74%, malaria = 66%). A study comparing the bio-
logical features of DF, malaria, and leptospirosis in India
showed similar results, observing that thrombocytopenia
was a predictor of malaria [29]. A previous study also
suggested that platelet counts were lower in patients with
malaria compared to patients with DF, especially at first
presentation [30]. This could be explained by the fact that
platelet counts in patients with DF are typically the lowest3–6 days from onset, when fever is about to decrease [31].
The cause of thrombocytopenia in DF is unknown, but
decreased production of platelets and increased destruction
of platelets in DHF have previously been described [21, 32].
Other explanations have been a direct infection of the
megakaryocytes by virus leading to increased destruction of
the platelets or increased antibodies directed against the
platelets [33]. Coagulopathy, which was not assessed in this
study, is also common in most patients with DF. Previous
studies have reported that prolonging of activated partial
thromboplastin time is quite common, whereas prothrom-
bin time was normal in the majority of patients [34–36].
In this study, co-infection of dengue and malaria was
not found. Previous reports rationalized that the main
habitat of malaria vectors is the forest [37], whereas the
main habitat of dengue vectors is the city [38]; that
immunity to either in its endemic area might prevent
infections [39]; and that co-infection can be easily
forgotten [40]. Although hematological parameters of
co-infected patients were not available in this study, a
previous study suggested that low HcT (<36%) and deep
thrombocytopenia (<50G/L) were significantly found in
Kotepui et al. Infectious Diseases of Poverty  (2017) 6:27 Page 8 of 9patients with a co-infection as compared to patients in-
fected just with malaria. In addition, low Hb (<12 g/dL),
low HcT (<36%), and deep thrombocytopenia (<50G/L)
were significantly found in patients with co-infections as
compared to patients infected just with dengue [41].
This study had certain limitations such as the fact
that the amount of days that patients had fever before
they were admitted to hospital could not be deter-
mined from the hospital’s database. In addition, this
study lacks of previous medical histories that may
confound the analysis such as Hb diseases, bacteria
or virus infection. Further study is needed to validate
whether the proposed parameters were likely to be
altered during the febrile stage of the illnesses and
whether the proposed indicators can differentiate
between dengue and malaria.Conclusions
The findings of this study suggest that several clinical
and laboratory measures could potentially distinguish
between patients with DF and those with malaria. The
sensitivity, specificity, positive predictive value (PLV),
negative predictive value (NPV), and diagnostic accuracy
for all hematological parameters were determined. A
tree decision model revealed that using neutrophils,
lymphocyte, MCHC, and gender was guided to discrim-
inate of patients with malaria and DF. This model may
be used to identify patients with dengue and those with
malaria, but it needs to be used in the early stages of the
illnesses in order for it to be useful for reducing
unnecessary medication and time of hospitalizations.Additional file
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